Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 15Esophageal Neoplasms 12Colorectal Neoplasms 9Stomach Neoplasms 6Rectal Neoplasms 6Esophageal Squamous Cell Carcinoma 6Pancreatic Neoplasms 5Neoplasms 4Liver Neoplasms 4Cholangiocarcinoma 4Neoplasm Metastasis 3Melanoma 3Carcinoma, Renal Cell 3Liver Diseases 2Gastrointestinal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Adenocarcinoma 2Waldenstrom Macroglobulinemia 1Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Unresectable Hepatocellular Carcinoma 1Unresectable Biliary Tract Cancer 1Triple Negative Breast Neoplasms 1Tongue Neoplasms 1Thyroid Neoplasms 1

Interventions

Oxaliplatin 3Fluorouracil 3Radiotherapy 2Immune Checkpoint Inhibitors 2Endoscopy 2Drug Therapy 2Chemoradiotherapy 2toripalimab 1tislelizumab 1pembrolizumab 1X-Rays 1Tretinoin 1TP protocol 1Surgical Procedures, Operative 1Radiotherapy, Intensity-Modulated 1Proctectomy 1Positron Emission Tomography Computed Tomography 1Neoadjuvant Therapy 1Magnetic Resonance Imaging 1Leucovorin 1Immunotherapy 1Immunohistochemistry 1Esophagectomy 1Epirubicin 1Dynamic Contrast Enhanced Magnetic Resonance Imaging 1Docetaxel 1Diffusion Magnetic Resonance Imaging 1Cisplatin 1Capecitabine 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pathologic Complete Response × Immunotherapy × Gastrointestinal × Clear all
NCT07397442 2026-02-11

Short-Course Radiotherapy Combined With Chemotherapy and Immunotherapy in Mid-Low Locally Advanced Rectal Cancer

Beijing Friendship Hospital

Phase 2 Not yet recruiting
19 enrolled
Gastrointestinal

Pathologic Complete Response, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡